PSA — What the Test Does and Does Not Settle
PSA screens for prostate cancer but cannot show what is causing an abnormal level. Screening and the treatment it can lead to may cause more harm than benefit for many men — a shared decision, not a box to tick.
A PSA test measures a protein made by the prostate and is used to screen for prostate cancer — but on its own it cannot show what is causing an abnormal level. There is genuine debate over its value: for many men, screening and the treatment it can lead to may cause more harm than benefit, which is why this is a shared decision with a clinician rather than a box to tick.
The biomarker
- Name: Prostate-Specific Antigen (PSA)
- Units: ng/mL
- Standard range: laboratory-specific; a 4 ng/mL cut-off was historically used, but current guidance emphasises shared decision-making over any single number.
- Optimal range: no threshold should be read as an action trigger on its own — age, trend, prostate size and the free-PSA fraction all change the interpretation.
How to read your result
| Pattern | What it means |
|---|---|
| What it measures | PSA in blood, produced by prostate tissue — benign and malignant alike. |
| A normal PSA | Does not exclude prostate cancer. |
| Raised, non-cancer causes | Benign prostatic enlargement, prostatitis, a urinary infection, recent ejaculation, cycling and some procedures all raise PSA without cancer being present. |
| Free-PSA ratio | Sometimes used to refine risk when total PSA is borderline. |
| Trend over threshold | The change across serial tests is generally more informative than a single value. |
What moves the needle
- No supplement lowers a meaningful PSA elevation — taking one only delays the conversation that matters.
- If raised, do not panic and do not act alone. A repeat test after several weeks is a common and reasonable next step.
- Before testing, avoid ejaculation and vigorous cycling for 48 hours before the draw, and mention any recent urinary infection or procedure.
- Decide with a clinician whether to test at all, based on your age, family history and how you weigh the trade-off.
Why this test is worth asking for
- Screening can find cancers that would never have caused harm; the resulting biopsies and treatments carry their own risks — the real trade-off worth understanding before testing.
- Family history of prostate cancer and Black ancestry both shift the risk calculation and are worth raising explicitly with a clinician.
- It is one of the few tests where deciding whether to order it is itself part of the medicine.
Sources
AgeGen lab guides are educational only. We do not provide medical diagnosis, prescribe brands, or recommend specific doses. Talk to a licensed clinician before changing your supplement or medication routine.
